SCHEMBL26115455

SCHEMBL26115455

O=C(NC1CC1OCc1ccccc1)[C@H]1CC[C@H](O)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
GAA P10253 1/20 0.44
KLK7 P49862 1/20 0.44
CPB1 P15086 1/20 0.44
PTGES O14684 3/20 0.43
PTGS2 P35354 3/20 0.43
TSHR P16473 1/20 0.42
NPC1 O15118 1/20 0.42
PKM P14618 1/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
BCHE P06276 1/20 0.42
MAPK1 P28482 1/20 0.42
MFN2 O95140 1/20 0.42
ATM Q13315 1/20 0.41
TACR1 P25103 2/20 0.41
LMNA P02545 1/20 0.41
SGMS2 Q8NHU3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30645029 1.00 ALDH1A1 (0.44) ALDH1A1GAAKLK7CPB1PTGES
SCHEMBL26112895 1.00 ALDH1A1 (0.44) ALDH1A1GAAKLK7CPB1PTGES
SCHEMBL26112723 0.87 MFN2 (0.46) ALDH1A1GAACPB1MEN1KMT2A
SCHEMBL26510111 0.87 MFN2 (0.46) ALDH1A1GAACPB1MEN1KMT2A
SCHEMBL30645043 0.85 MFN2 (0.49) MEN1KMT2AMAPK1MFN2LMNA
SCHEMBL26108764 0.85 MFN2 (0.49) MEN1KMT2AMAPK1MFN2LMNA
SCHEMBL26108759 0.85 MFN2 (0.49) MEN1KMT2AMAPK1MFN2LMNA
SCHEMBL25250950 0.80 BCHE (0.46) ALDH1A1GAACPB1MEN1KMT2A
SCHEMBL31187934 0.77 MFN2 (0.46) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL31470357 0.76 CPB1 (0.57) ALDH1A1GAACPB1TSHRTACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250332124-A1 MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF DORN II GERALD W (US) 2025-10-30 US disclosed
US-12396968-B2 Mitofusin activators having an endocyclic-bonded carbonyl group and methods for use thereof DORN II GERALD W (US) 2025-08-26 US disclosed
US-20240050386-A1 MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF DORN II GERALD W (US) 2024-02-15 US disclosed
WO-2023196340-A1 MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF DORN II GERALD W (US) 2023-10-12 WO disclosed
WO-2023196340-A1 MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF DORN II GERALD W (US) 2023-10-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12396968-B2 Mitofusin activators having an endocyclic-bonded carbonyl group and methods for use thereof MFN2, CYCS, CYC1 ALDH1A1 4715/4885GAA 2958/4885KLK7 3657/4885
US-20240050386-A1 MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF MFN2, CYCS, CYC1 ALDH1A1 4715/4885GAA 2958/4885KLK7 3657/4885
US-20250332124-A1 MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF MFN2, CYCS, CYC1 ALDH1A1 4722/4885GAA 2941/4885KLK7 3622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.